Literature DB >> 8817170

Persistence of immunity to poliomyelitis among a southern population that received four doses of OPV 5 to over 15 years before.

M Triassi1, G Ribera, L Barruffo, S Barbone, E Medda, M E Grandolfo.   

Abstract

The immune status against polioviruses was investigated in a population of 545 students aged 11-20 years residing in the Neapolitan area, who had completed the vaccination cycle with four doses of OPV 5 to over 15 years before. Assuming as unprotected those individuals without detectable neutralizing antibodies at the dilution 1:2, nobody resulted without protection against all types of poliovirus; 0.7% lacked antibodies only against type 1, 0.6% only against type 3 and none against type 2. A very slight decreasing trend was observed for GMT values in function of the distance from the last dose of OPV for polio 1 and 2, but not for polio 3. As expected, GMT values for polio 2 resulted higher than those for polio 1 and both were higher than those for polio 3, when calculated by age groups as well as by distance groups. The last four Italian cases of autochthonous paralytic poliomyelitis, occurred in the period 1981/83, regarded unvaccinated children aged 6 months-2 years, residing in the same geographical area to which the study population belong. In the same area a delay of immunization practices was also ascertained in the recent past. Results of this study confirm that a priority for public health services is to devote their human and economic resources to reduce the vaccination delay more than administrate a further fifth dose of OPV at the age of twelve.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8817170     DOI: 10.1007/bf00144420

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  6 in total

1.  Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before.

Authors:  E Bellelli; M L Tanzi; V Bocelli; U Bracchi; P Affanni
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

2.  Serum antibodies to polioviruses in a Tuscan population, Italy.

Authors:  D Reali; A Carducci; M A Ruschi
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

3.  Persistence of poliovirus-neutralizing antibodies 2-16 years after immunization with live attenuated vaccine. A seroepidemiologic survey in the mainland of Venice.

Authors:  R Trivello; G Renzulli; G Farisano; C Bonello; M Moschen; V Gasparini; G Benussi
Journal:  Epidemiol Infect       Date:  1988-12       Impact factor: 2.451

Review 4.  Herd immunity: history, theory, practice.

Authors:  P E Fine
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

5.  Serum antibodies to poliomyelitis in Italy.

Authors:  R Santoro; F Lombardi; F Novello; C Amato; F M Ruggeri; M E Grandolfo; I Annesi; C M Cortellessa; F Timperi; R Inglese
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

6.  Paralytic poliomyelitis in Italy (1981-85).

Authors:  F Novello; F Lombardi; C Amato; R Santoro; L Fiore; M E Grandolfo; P Pasquini
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

  6 in total
  1 in total

1.  Successes and shortcomings of polio eradication: a transmission modeling analysis.

Authors:  Bryan T Mayer; Joseph N S Eisenberg; Christopher J Henry; M Gabriela M Gomes; Edward L Ionides; James S Koopman
Journal:  Am J Epidemiol       Date:  2013-04-16       Impact factor: 4.897

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.